je.st
news
Pfizer net down on lower sales, higher research, legal costs
2015-01-27 15:37:07| Biotech - Topix.net
Pfizer Inc.'s fourth-quarter profit fell by half as worsening generic competition and unfavorable currency rates reduced sales, and higher research spending and legal costs also hurt the bottom line. The world's second-biggest drugmaker by revenue reported lower sales for most of its huge portfolio of prescription medicines, with the biggest hit coming from new generic competition to popular painkiller Celebrex.
Tags: net
research
legal
sales
Category:Biotechnology and Pharmaceuticals